EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthetic Heparan Sulfate-like Oligosaccharides as Tools to Decipher Growth Factor Recognition

Joseph Wakpal, Kartikey Singh iD, Michael Hotor iD, Livia Philip iD, Dylan Yost-Slinker, Junzhe Wang iD, Hawau Abdulsalam iD, Hien M Nguyen iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c00760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Joseph Wakpal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Wayne State University, Detroit, Michigan48202, United States. Hauptthemen laut MEDLINE: Heparan Sulfate, Oligosaccharides. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparan sulfate proteoglycans (HSPGs) facilitate interactions between growth factors and their receptors, regulating signaling pathways involved in angiogenesis and cell proliferation. However, the structural heterogeneity and synthetic inaccessibility of native heparan sulfate (HS) have limited systematic exploration of structure–activity relationships (SAR) and the discovery of HS-based inhibitors. Here, we developed 46 aminoglycoside-derived non-native HS mimetics spanning diverse structural and functional group patterns. SAR analysis identified N-acetylation and 6-O-sulfation as key determinants of HS-FGF2 and HS–VEGF165 interaction modulation. Compound 8, synthesized in two steps, competitively disrupted heparin binding to FGF2 (IC50 = 0.23 μM), FGFR1 (IC50 = 0.17 μM), and VEGF165 (IC50 = 0.66 μM), with >140-fold FGF2/FGF4 selectivity and substantially greater potency than native HS pentasaccharide fondaparinux. In NIH3T3 fibroblasts, compound 8 selectively reduced FGF2-induced proliferation in a dose-dependent manner without measurable cytotoxicity, highlighting aminoglycoside-derived HS mimetics as synthetically accessible platforms for modulating growth factor signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heparan SulfateOligosaccharidesAnimalsMiceStructure-Activity RelationshipNIH 3T3 CellsHumansFibroblast Growth Factor 2Cell ProliferationAminoglycosidesVascular Endothelial Growth Factor AReceptor, Fibroblast Growth Factor, Type 1

Substanzen

Heparan SulfateOligosaccharidesFibroblast Growth Factor 2AminoglycosidesVascular Endothelial Growth Factor AReceptor, Fibroblast Growth Factor, Type 1

Autor:innen und Institutionen

  • Department of Chemistry, Wayne State University, Detroit, Michigan48202, United States.

ORCID-Profile: Kartikey Singh, Michael Hotor, Livia Philip, Junzhe Wang, Hawau Abdulsalam, Hien M Nguyen

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Wakpal, J., Singh, K., Hotor, M., Philip, L., Yost-Slinker, D., Wang, J., Abdulsalam, H., & Nguyen, H. M. (2026). Synthetic Heparan Sulfate-like Oligosaccharides as Tools to Decipher Growth Factor Recognition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00760

Vancouver

Wakpal J, Singh K, Hotor M, Philip L, Yost-Slinker D, Wang J, et al. Synthetic Heparan Sulfate-like Oligosaccharides as Tools to Decipher Growth Factor Recognition. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00760

BibTeX
@article{Wakpal2026,
  author = {Wakpal, Joseph and Singh, Kartikey and Hotor, Michael and Philip, Livia and Yost-Slinker, Dylan and Wang, Junzhe and Abdulsalam, Hawau and Nguyen, Hien M},
  title = {Synthetic Heparan Sulfate-like Oligosaccharides as Tools to Decipher Growth Factor Recognition},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c00760}
}
Kostenlos starten →